BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18245481)

  • 1. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.
    Yin L; Castagnino P; Assoian RK
    Cancer Res; 2008 Feb; 68(3):800-7. PubMed ID: 18245481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
    Qu H; Fang L; Duan L; Long X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.
    Kabashima A; Higuchi H; Takaishi H; Matsuzaki Y; Suzuki S; Izumiya M; Iizuka H; Sakai G; Hozawa S; Azuma T; Hibi T
    Int J Cancer; 2009 Jun; 124(12):2771-9. PubMed ID: 19296540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side population cells in human gallbladder cancer cell line GBC-SD regulated by TGF-β-induced epithelial-mesenchymal transition.
    Zhang Z; Zhu F; Xiao L; Wang M; Tian R; Shi C; Qin R
    J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):749-755. PubMed ID: 22173493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective knock down of very high ABCG2 expression by a hammerhead ribozyme.
    Kowalski P; Farley KM; Lage H; Schneider E
    Anticancer Res; 2004; 24(4):2231-5. PubMed ID: 15330166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
    Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
    Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
    Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.
    Christgen M; Ballmaier M; Bruchhardt H; von Wasielewski R; Kreipe H; Lehmann U
    Mol Cell Biochem; 2007 Dec; 306(1-2):201-12. PubMed ID: 17660947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
    Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
    Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between PXR and ABCG2 patterns of mRNA expression in a MCF7 breast carcinoma cell derivative upon induction by proinflammatory cytokines.
    Malekshah OM; Bahrami AR; Afshari JT; Mosaffa F; Behravan J
    DNA Cell Biol; 2011 Jan; 30(1):25-31. PubMed ID: 20846001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.
    Ehata S; Johansson E; Katayama R; Koike S; Watanabe A; Hoshino Y; Katsuno Y; Komuro A; Koinuma D; Kano MR; Yashiro M; Hirakawa K; Aburatani H; Fujita N; Miyazono K
    Oncogene; 2011 Apr; 30(14):1693-705. PubMed ID: 21132002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
    Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S
    Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
    Imai Y; Ishikawa E; Asada S; Sugimoto Y
    Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
    Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
    Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.
    Wang J; Guo LP; Chen LZ; Zeng YX; Lu SH
    Cancer Res; 2007 Apr; 67(8):3716-24. PubMed ID: 17440084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer.
    Janakiraman H; Nobukiyo A; Inoue H; Kanno M
    Hiroshima J Med Sci; 2011 Jun; 60(2):25-35. PubMed ID: 21970185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
    Hiraga T; Ito S; Nakamura H
    Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.